These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38220121)

  • 21. A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.
    Ueda H; Muranushi N; Sakuma S; Ida Y; Endoh T; Kadota K; Tozuka Y
    Pharm Res; 2016 Apr; 33(4):1018-29. PubMed ID: 26700604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid-liquid miscibility gaps in drug-water binary systems: crystal structure and thermodynamic properties of prilocaine and the temperature-composition phase diagram of the prilocaine-water system.
    Rietveld IB; Perrin MA; Toscani S; Barrio M; Nicolai B; Tamarit JL; Ceolin R
    Mol Pharm; 2013 Apr; 10(4):1332-9. PubMed ID: 23339548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems.
    Wu W; Wang Y; Löbmann K; Grohganz H; Rades T
    Mol Pharm; 2019 Mar; 16(3):1294-1304. PubMed ID: 30624075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
    Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement.
    Li W; Song J; Li J; Li M; Tian B; He Z; Liu X; Fu Q
    Int J Pharm; 2021 Sep; 607():120971. PubMed ID: 34363915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.
    Löbmann K; Laitinen R; Strachan C; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):882-8. PubMed ID: 23567485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.
    Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of electrostatic interactions on the relaxation dynamics of pharmaceutical eutectics.
    Wojnarowska Z; Zotowa J; Knapik-Kowalczuk J; Tajber L; Paluch M
    Eur J Pharm Sci; 2019 Jun; 134():93-101. PubMed ID: 30986473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of rivaroxaban amorphous solid dispersions physical stability via molecular mobility studies and molecular simulations.
    Kapourani A; Eleftheriadou K; Kontogiannopoulos KN; Barmpalexis P
    Eur J Pharm Sci; 2021 Feb; 157():105642. PubMed ID: 33189903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platensimycin-berberine chloride co-amorphous drug system: Sustained release and prolonged half-life.
    Wang Z; Chen X; Li D; Bai E; Zhang H; Duan Y; Huang Y
    Eur J Pharm Biopharm; 2022 Oct; 179():126-136. PubMed ID: 36087879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the physical stability of three nimesulide-indomethacin co-amorphous systems from the perspective of molecular aggregates.
    Wang M; Liu S; Jia L; Zhang J; Du S; Gong J
    Eur J Pharm Sci; 2020 Apr; 147():105294. PubMed ID: 32147483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Int J Pharm; 2017 Jun; 526(1-2):88-94. PubMed ID: 28392278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Co-amorphous technology to improve dissolution and physical stability of silybin].
    Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micellization and gelation in block copolymer systems containing local anesthetics.
    Scherlund M; Brodin A; Malmsten M
    Int J Pharm; 2000 Dec; 211(1-2):37-49. PubMed ID: 11137337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Craig D; Qi S
    Pharm Res; 2015 Apr; 32(4):1210-28. PubMed ID: 25270572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms.
    Chen J; Li H; Li X; Yuan D; Cheng H; Ke Y; Cheng J; Wang Z; Chen J; Li J
    Eur J Pharm Biopharm; 2022 Sep; 178():82-93. PubMed ID: 35932965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.